Premenstrual syndrome (PMS) is any of a complex of symptoms experienced by some women in the days immediately before menstruation
Aetiology
The vast majority of women (95%) get premenstrual symptoms, however to be classed as PMS the symptoms must impact on daily living
Four in ten women (40%) experience symptoms of PMS and of these 5–8% suffer from severe PMS
Pathophysiology
Not clearly understood
Sensitivity to progesterone - serum concentrations of oestrogen and progesterone the same in those with and without PMS
Serotonin receptors are responsive to oestrogen and progesterone, and selective serotonin reuptake inhibitors (SSRIs) are proven to reduce PMS symptoms
GABA (γ-aminobutyric acid) levels are modulated by the metabolite of progesterone, allopregnanolone, and in women with PMS the allopregnanolone levels appear to be reduced
Clinical features
Symptoms must be present in luteal phase, abate during menstruation followed by a symptom free week